(Q36154134)

12 August 2017

Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance (English)

1 reference

12 August 2017

1 reference

Taylor RG

1

1 reference

12 August 2017

Pavia D

2

1 reference

12 August 2017

Agnew JE

3

1 reference

12 August 2017

Lopez-Vidriero MT

4

1 reference

12 August 2017

Newman SP

5

1 reference

12 August 2017

Lennard-Jones T

6

1 reference

12 August 2017

Clarke SW

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 1986

1 reference

12 August 2017

1 reference

12 August 2017

41

1 reference

12 August 2017

4

1 reference

12 August 2017

295-300

1 reference

Ipratropium bromide in acute asthma.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Anticholinergic, Antimuscarinic Bronchodilators1,2

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Measurement of bronchial mucociliary clearance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Bronchoconstriction in response to ipratropium bromide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Adverse reaction to ipratropium bromide.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

How should a pressurized beta-adrenergic bronchodilator be inhaled?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Lung defense mechanisms (first of two parts)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Ipratropium bromide: mucociliary clearance rate and airway resistance in normal subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Sch 1000: a new anticholinergic bronchodilator

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Aerosol Sch 1000. An anticholinergic bronchodilator

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Radionuclide demonstration of ventilatory abnormalities in mild asthma.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=460313

Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma

23 September 2018

1 reference

12 December 2020

Human alveolar deposition of 4 micron teflon particles

1 reference

12 December 2020

Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamol

1 reference

12 December 2020

The effect of oral aminophylline on lung mucociliary clearance in man

1 reference

12 December 2020

Sputum viscosity and long-term ipratropium bromide nebuliser therapy

1 reference

12 December 2020

Drug effects on mucociliary function

1 reference

12 December 2020

Acute effect of ipratropium bromide at therapeutic dose on mucus transport of adult asthmatics

1 reference

12 December 2020

Sputum Changes Associated with the Use of Ipratropium Bromide

1 reference

12 December 2020

Inhibition of mucociliary clearance from the human lung by hyoscine

1 reference

12 December 2020

Comparative Trial of a New Anticholinergic Bronchodilator, Sch 1000, and Salbutamol in Chronic Bronchitis

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.41.4.295

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

2943050

1 reference